Comparison of Different Cardiovascular Risk Score and Pulse Wave Velocity-Based Methods for Vascular Age Calculation

被引:15
作者
Gyongyosi, Helga [1 ]
Korosi, Beata [1 ]
Batta, Dora [1 ]
Nemcsik-Bencze, Zsofia [2 ]
Laszlo, Andrea [3 ]
Tisler, Andras [4 ]
Cseprekal, Orsolya [5 ]
Torzsa, Peter [1 ]
Eorsi, Daniel [1 ]
Nemcsik, Janos [1 ,6 ]
机构
[1] Semmelweis Univ, Dept Family Med, 7-9 Stahly St, H-1085 Budapest, Hungary
[2] Semmelweis Univ, Med Imaging Ctr, Dept Radiol, Budapest, Hungary
[3] GP Practice Jula Schindler, Nurnberg, Germany
[4] Semmelweis Univ, Dept Internal Med & Oncol, Budapest, Hungary
[5] Semmelweis Univ, Dept Transplantat & Surg, Budapest, Hungary
[6] Hlth Serv Zuglo ZESZ, Budapest, Hungary
关键词
Vascular age; Risk scores; Arterial stiffness; Pulse wave velocity; BLOOD-PRESSURE; ASSOCIATION; STIFFNESS;
D O I
10.1016/j.hlc.2021.06.518
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The calculation of vascular age can help patients understand the importance of adherence to healthy lifestyle and medications. However, multiple methods are available to calculate vascular age and no comparison data is available yet. Our aim was to evaluate vascular age based on the Framingham Risk Score (FRS), the Systematic COronary Risk Evaluation (SCORE) and carotid-femoral pulse wave velocity (PWV). Methods Consecutive subjects between the age of 40-65 years, who took part in a screening program in three general practitioner practices were involved. PWV was measured by tonometry and was compared with normal values. Vascular age was defined based on FRS and SCORE according to literature data. Results One hundred and seventy-two (172) patients were involved. The median chronological age was 55.5 (48.8-61.2) years. The median vascular age based on FRS and SCORE were 64 (54-79) years and 55 (44.2-60.7) years, respectively (p<0.05). Based on PWV, FRS and SCORE, 40.1%, 78.5% and 32% of the subjects had increased vascular age compared with chronological age, respectively (PWV+, FRS1, SCORE+, p<0.05). Fifty-eight (58) (84%) of the PWV+ subjects were also FRS+, and this proportion was high in case of SCORE+ patients as well (n=47, 85.4%). However, only moderate overlap was found between PWV+ and SCORE+ subjects as 17 (30.9%) of SCORE+ patients were also PWV+. Conclusion The differences found between the calculated vascular ages and the proportion of subjects with elevated vascular age warrants further detailed comparison of different vascular age calculation methods.
引用
收藏
页码:1744 / 1751
页数:8
相关论文
共 20 条
[1]   Resistant hypertension: Diagnosis, evaluation, and treatment - A Scientific Statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research [J].
Calhoun, David A. ;
Jones, Daniel ;
Textor, Stephen ;
Goff, David C. ;
Murphy, Timothy P. ;
Toto, Robert D. ;
White, Anthony ;
Cushman, William C. ;
White, William ;
Sica, Domenic ;
Ferdinand, Keith ;
Giles, Thomas D. ;
Falkner, Bonita ;
Carey, Robert M. .
HYPERTENSION, 2008, 51 (06) :1403-1419
[2]   Addressing the Unmet Needs of Measuring Vascular Ageing in Clinical Practice-European COoperation in Science and Technology Action VascAgeNet [J].
Climie, Rachel Emma ;
Mayer, Christopher Clemens ;
Bruno, Rosa Maria ;
Hametner, Bernhard .
ARTERY RESEARCH, 2020, 26 (02) :71-75
[3]   Estimation of ten-year risk of fatal cardiovascular disease in Europe:: the SCORE project [J].
Conroy, RM ;
Pyörälä, K ;
Fitzgerald, AP ;
Sans, S ;
Menotti, A ;
De Backer, G ;
De Bacquer, D ;
Ducimetière, P ;
Jousilahti, P ;
Keil, U ;
Njolstad, I ;
Oganov, RG ;
Thomsen, T ;
Tunstall-Pedoe, H ;
Tverdal, A ;
Wedel, H ;
Whincup, P ;
Wilhelmsen, L ;
Graham, IM .
EUROPEAN HEART JOURNAL, 2003, 24 (11) :987-1003
[4]   How to calculate vascular age with the SCORE project scales: a new method of cardiovascular risk evaluation [J].
Cuende, Jose I. ;
Cuende, Natividad ;
Calaveras-Lagartos, Javier .
EUROPEAN HEART JOURNAL, 2010, 31 (19) :2351-2358
[5]   General cardiovascular risk profile for use in primary care - The Framingham Heart Study [J].
D'Agostino, Ralph B. ;
Vasan, Ramachandran S. ;
Pencina, Michael J. ;
Wolf, Philip A. ;
Cobain, Mark ;
Massaro, Joseph M. ;
Kannel, William B. .
CIRCULATION, 2008, 117 (06) :743-753
[6]  
Estruch R, 2018, NEW ENGL J MED, V378, DOI [10.1056/NEJMoa1800389, 10.1056/NEJMoa1200303, 10.1056/nejmoa1800389]
[7]   Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis [J].
Ettehad, Dena ;
Emdin, Connor A. ;
Kiran, Amit ;
Anderson, Simon G. ;
Callender, Thomas ;
Emberson, Jonathan ;
Chalmers, John ;
Rodgers, Anthony ;
Rahimi, Kazem .
LANCET, 2016, 387 (10022) :957-967
[8]   Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials [J].
He, Feng J. ;
Li, Jiafu ;
MacGregor, Graham A. .
BMJ-BRITISH MEDICAL JOURNAL, 2013, 346
[9]   Risks associated with permanent discontinuation of blood pressure-lowering medications in patients with type 2 diabetes [J].
Hirakawa, Yoichiro ;
Arima, Hisatomi ;
Webster, Ruth ;
Zoungas, Sophia ;
Li, Qiang ;
Harrap, Stephen ;
Liu Lisheng ;
Hamet, Pavel ;
Mancia, Giuseppe ;
Poulter, Neil ;
Neal, Bruce ;
Williams, Bryan ;
Rogers, Anthony ;
Woodward, Mark ;
Chalmers, John .
JOURNAL OF HYPERTENSION, 2016, 34 (04) :781-787
[10]   Exercise Capacity and Mortality in Hypertensive Men With and Without Additional Risk Factors [J].
Kokkinos, Peter ;
Manolis, Athanasios ;
Pittaras, Andreas ;
Doumas, Michael ;
Giannelou, Angeliki ;
Panagiotakos, Demosthenes B. ;
Faselis, Charles ;
Narayan, Puneet ;
Singh, Steven ;
Myers, Jonathan .
HYPERTENSION, 2009, 53 (03) :494-499